The Maker of AeroChamber Plus® Joins with AARC as a Corporate Partner

For Immediate Release
DALLAS (November 25, 2003) —   Monaghan Medical Corporation (MMC) recently united with the American Association for Respiratory Care (AARC) in its Corporate Partner Program. As a partner , Monaghan has further pledged its commitment to serve by supporting the only national Association exclusive to the respiratory community.

“Companies, such as Monaghan, that make up the respiratory care industry are an important part of our community. We rely on them to provide us with the cutting-edge technologies we need to deliver care, and they rely on us to provide input into research and development of their new and ongoing products,” says Kevin Shrake, MA, RRT, FAARC, AARC's Chief Operating Officer.

This alliance will help Monaghan Medical create technologies that enable respiratory therapists to better meet the needs of respiratory patients. Monaghan can help provide professional support and education, while as a Corporate Partner they can receive input from respiratory health professionals on their research and development projects.

Mitch Baran, President and CEO of MMC, noted that, “ Monaghan has always supported the efforts of the AARC and is proud to have been a part of many of its programs and initiatives . We are honored to be a partner and look forward to working closely with the AARC in the respiratory community.“  

About the AARC
The AARC, the only professional membership association for respiratory therapists, focuses primarily on respiratory therapy education and research. Its goals are to ensure that respiratory patients receive safe and effective care from qualified professionals and to benefit respiratory health care providers. The Association continues to advocate, on behalf of pulmonary patients, for appropriate access to respiratory services provided by qualified professionals.

About MMC
Monaghan Medical Corporation is a global leader in the manufacture and sale of aerosol drug delivery devices and asthma management products as well as a supplier to major pharmaceutical companies involved with respiratory medicine in the United States. The company's strength lies in its science based approach to developing cost efficient, outcome based products for aerosolized drug delivery including the well known brand names AeroChamber Plus® Valved Holding Chamber, AeroVent® Collapsible Holding Chamber, AeroEclipse® Breath Actuated Nebulizer, and TruZone™ Peak Flow Meter. Detailed clinical and contact information can be found on the companies website, www.monaghanmed.com.

# # #

Contact:
Sherry Milligan
Communications Manager
972-406-4690, Milligan@aarc.org